The efficacy and safety of combinations of SGLT2 inhibitors and GLP-1 receptor agonists in the treatment of type 2 diabetes or obese adults: a systematic review and meta-analysis

被引:0
作者
Man Guo
Junling Gu
Fangyuan Teng
Jiao Chen
Xiumei Ma
Qing Chen
Yueli Pu
Zongzhe Jiang
Yang Long
Yong Xu
机构
[1] Nephropathy Clinical Medical Research Center of Sichuan Province,Department of Diabetes and Endocrinology
[2] Affiliated Hospital of Southwest Medical University,Faculty of Chinese Medicine
[3] Macau University of Science and Technology,Department of Endocrinology
[4] State Key Laboratory of Quality Research in Chinese Medicine,undefined
[5] Macau University of Science and Technology,undefined
[6] Sichuan Mental Health Center,undefined
来源
Endocrine | 2020年 / 67卷
关键词
SGLT2 inhibitors; GLP-1 agonists; Type 2 diabetes mellitus; Obesity; Meta-analysis;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:294 / 304
页数:10
相关论文
共 96 条
[41]  
Frías JP(undefined)undefined undefined undefined undefined-undefined
[42]  
Tinahones FJ(undefined)undefined undefined undefined undefined-undefined
[43]  
Saroka RM(undefined)undefined undefined undefined undefined-undefined
[44]  
Kane MP(undefined)undefined undefined undefined undefined-undefined
[45]  
Busch RS(undefined)undefined undefined undefined undefined-undefined
[46]  
Fulcher G(undefined)undefined undefined undefined undefined-undefined
[47]  
Matthews DR(undefined)undefined undefined undefined undefined-undefined
[48]  
Perkovic V(undefined)undefined undefined undefined undefined-undefined
[49]  
Deol H(undefined)undefined undefined undefined undefined-undefined
[50]  
Lekkakou L(undefined)undefined undefined undefined undefined-undefined